PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Finding brings scientists 1 step closer to Parkinson's drug

Long-term aim is to develop new treatments to block the spread of damaged proteins in the brain

2012-06-28
(Press-News.org) Grand Rapids, Mich. (June 27, 2012) –Van Andel Institute announces that researchers at Lund University in Sweden have published a study detailing how Parkinson's disease spreads through the brain. Experiments in rat models uncover a process previously used to explain mad cow disease, in which misfolded proteins travel from sick to healthy cells. This model has never before been identified so clearly in a living organism, and the breakthrough brings researchers one step closer to a disease-modifying drug for Parkinson's.

"Parkinson's is the second most common neurodegenerative disorder after Alzheimer's disease," said Patrik Brundin M.D., Ph.D., Jay Van Andel Endowed Chair in Parkinson's Research at Van Andel Research Institute (VARI), Head of the Neuronal Survival Unit at Lund University and senior author of the study. "A major unmet medical need is a therapy that slows disease progression. We aim to better understand how Parkinson's pathology progresses and thereby uncover novel molecular targets for disease-modifying treatments."

Previous research demonstrates that a misfolded protein known as alpha-synuclein protein gradually appears in healthy young neurons transplanted to the brains of Parkinson's patients. This discovery gave rise to the group's hypothesis of cell-to-cell protein transfer, which has since been demonstrated in laboratory experiments.

In the current study, published this week in the PLoS ONE, researchers for the first time were able to follow events in the recipient cell as it accepts the diseased protein by allowing it to pass its outer cell membrane. The experiments also show how the transferred proteins attract proteins in the host cell leading to abnormal folding or "clumping" inside the cells.

"This is a cellular process likely to lead to the disease process as Parkinson's progresses, and it spreads to an increasing number of brain regions as the patient gets sicker," said Elodie Angot, Ph.D., of Lund University's Neuronal Survival Unit, and lead co-author of the study.

"In our experiments, we show a core of unhealthy human alpha-synuclein protein surrounded by alpha-synuclein produced by the rat itself. This indicates that this misfolded protein not only moves between cells but also acts as a "seed" attracting proteins produced by the rat's brain cells," said Jennifer Steiner, Ph.D., of Lund University and Van Andel Institute's Center for Neurodegenerative Science, the study's other lead author.

These findings are consistent with results from previous laboratory cell models and for the first time extend this observation into a living organism. However, it remains unclear exactly how alpha-synuclein gains access from the extracellular space to the cytoplasm of cells to act as a template for naturally occurring alpha-synuclein, causing the naturally-occurring protein to, in turn, misfold. Further studies are needed to clarify this important step in the process.

The discovery does not reveal the root of Parkinson's disease, but in conjunction with disease models developed by Lund University researchers and others, could enable scientists to develop new drug targets aimed at mitigating or slowing the effects of the disease, which currently strikes more than 1% of people over the age of 65.

INFORMATION:

Link to the study here: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0039465

About the Neuronal Survival Unit, Faculty of Medicine, Lund University:

The research at Neuronal Survival Unit, Lund University, Sweden is focused on pathogenetic mechanisms and pharmacological treatment in cell and animal models of Parkinson's and Alzheimer's diseases. We also study cell replacement therapy with stem cells in attempts to repair brains in animal models of Parkinson's diseases. The group's mission is to understand neurodegenerative diseases and develop new therapies that are of benefit to patients and their caregivers. http://www.med.lu.se/expmed/neuronal_survival_unit

About Van Andel Research Institute:

Established by Jay and Betty Van Andel in 1996, Van Andel Institute is an independent research organization dedicated to preserving, enhancing and expanding the frontiers of medical science, and to achieving excellence in education by probing fundamental issues of education and the learning process. This is accomplished through the work of over 200 researchers in more than 20 on-site laboratories and in collaborative partnerships that span the globe. www.vai.org

END



ELSE PRESS RELEASES FROM THIS DATE:

A step toward minute factories that produce medicine inside the body

2012-06-28
Scientists are reporting an advance toward treating disease with minute capsules containing not drugs — but the DNA and other biological machinery for making the drug. In an article in ACS' journal Nano Letters, they describe engineering micro- and nano-sized capsules that contain the genetically coded instructions, plus the read-out gear and assembly line for protein synthesis that can be switched on with an external signal. Daniel Anderson and colleagues explain that development of nanoscale production units for protein-based drugs in the human body may provide a new ...

Racial make-up of community impacts obesity risk

2012-06-28
The racial and ethnic composition of a community is associated with the obesity risk of individuals living within the community, according to a study led by researchers at the Agency for Healthcare Research and Quality (AHRQ) and the Johns Hopkins Bloomberg School of Public Health. The findings, published in the June 14 edition of the American Journal of Public Health, may help explain disparities in obesity rates among racial groups and point to some of the environmental factors that may contribute to obesity in the United States. For the study, the researchers analyzed ...

EARTH: 5 outstanding questions in Earth science

2012-06-28
Alexandria, VA – What are today's biggest unanswered questions in earth science? In the July issue of EARTH Magazine, experts from a variety of disciplines weigh in on what they consider to be the biggest unsolved mysteries across the geosciences and how they think we may solve them. Of course, in science, answering one question typically floods the field with new questions and thus new lines of investigation. For example, the discovery in the mid-19th century that carbon dioxide traps heat in Earth's atmosphere led scientists to engage in lengthy studies – many that ...

Math goes to the movies

2012-06-28
Minneapolis, MN—27 June, 2012—What do Avatar, The Chronicles of Narnia, X-Men, Harry Potter, and Pirates of the Caribbean have in common? Simulated physics. That's right. Making visual effects real for movie audiences—be it Avatar's vast ocean surface or rising water levels in The Deathly Hallows—requires quite a bit of physics and math. Physical equations and scientific computations are generated behind the scenes to ensure that the elements you see on the big screen obey the same laws of physics as their real counterparts. One mathematician who helps ensure the ...

New screening test to help people with hearing loss in China

2012-06-28
The University of Southampton has developed a new hearing screening test which could help the estimated 100 million people suffering from hearing loss in China. This new Chinese version is based on a hearing screening test developed by the University's Institute of Sound and Vibration Research (ISVR), which has already been taken by more than a million people across Europe. The tests aim to address the fact that hundreds of millions of people worldwide have hearing loss but only a fraction obtain hearing aids that would help them to overcome hearing difficulties. The ...

New drug dramatically improves survival in Hodgkin lymphoma patients

2012-06-28
MAYWOOD, Il. -- A new cancer drug with remarkably few side effects is dramatically improving survival in Hodgkin lymphoma patients who fail other treatments and are nearly out of options. Loyola University Medical Center oncologist Scott E. Smith, MD, PhD presented survival data for the drug, brentuximab vedotin (Adcetris®), at the 17th Congress of the European Hematology Association. Smith is director of Loyola's Hematological Malignancies Research Program. The multi-center study included 102 Hodgkin lymphoma patients who had relapsed after stem cell transplants. Tumors ...

Menopausal women could 'work out' their hot flashes

2012-06-28
Menopausal women who exercise may experience fewer hot flashes in the 24 hours following physical activity, according to health researchers. In general, women who are relatively inactive or are overweight or obese tend to have a risk of increased symptoms of perceived hot flashes, noted Steriani Elavsky, assistant professor of kinesiology at Penn State. Perceived hot flashes do not always correspond to actual hot flashes. Most previous research analyzed only self-reported hot flashes. This is the first study known to the researchers to look at objective versus subjective ...

Women 'never the right age' in hedge fund

2012-06-28
Women working in hedge funds struggle to be taken seriously at work, according to a new study from two leading management experts. The report from the universities of Leicester and Essex looked into the concept of "adulting" which is defined as the attempt by people to be seen as mature and responsible, professionally and socially. The academics, who looked at men and women at a London hedge fund, found that women faced problems at every stage of adult life – from getting started in the company to keeping credibility among colleagues after giving birth. By contrast, ...

Brain scans detect early signs of autism

2012-06-28
A new study shows significant differences in brain development in high-risk infants who develop autism starting as early as age 6 months. The findings published in the American Journal of Psychiatry reveal that this abnormal brain development may be detected before the appearance of autism symptoms in an infant's first year of life. Autism is typically diagnosed around the age of 2 or 3. The study offers new clues for early diagnosis, which is key, as research suggests that the symptoms of autism - problems with communication, social interaction and behavior - can improve ...

Dying trees in Southwest set stage for erosion, water loss in Colorado River

2012-06-28
CORVALLIS, Ore. – New research concludes that a one-two punch of drought and mountain pine beetle attacks are the primary forces that have killed more than 2.5 million acres of pinyon pine and juniper trees in the American Southwest during the past 15 years, setting the stage for further ecological disruption. The widespread dieback of these tree species is a special concern, scientists say, because they are some of the last trees that can hold together a fragile ecosystem, nourish other plant and animal species, and prevent serious soil erosion. The major form of soil ...

LAST 30 PRESS RELEASES:

New study sheds light on Milky Way's mysterious chemical history

Could altering the daily timing of immunotherapy improve survival in people with cancer?

Weaving secondary battery electrodes with fibers and tying them like ropes for both durability and performance

Using social media may impair children’s attention

Science briefing: An update on GLP-1 drugs for obesity

Lower doses of immunotherapy for skin cancer give better results

Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

[Press-News.org] Finding brings scientists 1 step closer to Parkinson's drug
Long-term aim is to develop new treatments to block the spread of damaged proteins in the brain